Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

Xbrane Biopharma AB (publ) (XBRANE.ST)

Compare
0.1800
-0.0088
(-4.66%)
At close: April 4 at 5:29:46 PM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-308,765
-133,728
-406,678
-193,918
-219,610
Investing Cash Flow
-35,122
-52,246
-16,769
-60,125
-77,350
Financing Cash Flow
212,767
243,623
298,696
148,864
349,365
End Cash Position
36,164
124,330
65,402
193,994
295,180
Capital Expenditure
-35,122
-52,246
-16,769
-60,125
-77,350
Issuance of Capital Stock
337,242
337,242
120,018
170,551
380,870
Issuance of Debt
50,000
70,000
225,000
--
--
Repayment of Debt
-122,916
-112,500
-20,833
--
--
Free Cash Flow
-343,887
-185,974
-423,447
-254,043
-296,960
12/31/2021 - 2/3/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers